Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Galapagos NV
  6. News
  7. Summary
    GLPG   BE0003818359

GALAPAGOS NV

(GLPG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Galapagos : COO Takes On President Role

03/25/2021 | 12:38am EDT


ę MT Newswires 2021
All news about GALAPAGOS NV
06/23GALAPAGOSá : announces departure of CSO Piet Wigerinck later this year (Form 6-K..
PU
06/23GALAPAGOSá : Chief Scientific Officer To Step Down
MT
06/22GALAPAGOSá : Chief Scientific Officer to Leave Company Later This Year
MT
06/08GALAPAGOSá : increases share capital through subscription right exercises (Form ..
PU
06/07Galapagos increases share capital through subscription right exercises
GL
06/04GALAPAGOSá : SELECTION study on filgotinib in ulcerative colitis published in Th..
PU
06/04GALAPAGOSá : Anti-inflammatory Drug Jyseleca Sustains Efficacy in Maintenance St..
MT
05/28GALAPAGOSá : to present data on rheumatoid arthritis at the upcoming European Le..
PU
05/19GALAPAGOSá : announces first patient enrolled in FILOSOPHY study to advance unde..
PU
05/19GALAPAGOSá : Enrolls First Patient in Post-Approval Study of Arthritis Drug
MT
More news
Financials
Sales 2021 521 M 622 M 622 M
Net income 2021 -249 M -297 M -297 M
Net cash 2021 3 523 M 4 203 M 4 203 M
P/E ratio 2021 -17,1x
Yield 2021 -
Capitalization 3 774 M 4 502 M 4 503 M
EV / Sales 2021 0,48x
EV / Sales 2022 1,09x
Nbr of Employees 1 328
Free-Float 73,8%
Chart GALAPAGOS NV
Duration : Period :
Galapagos NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GALAPAGOS NV
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Last Close Price 57,60 €
Average target price 76,21 €
Spread / Average Target 32,3%
EPS Revisions
Managers and Directors
NameTitle
Onno van de Stolpe Chief Executive Officer
Bart Filius President & Chief Operating Officer
Raj B. Parekh Chairman
Piet Wigerinck Chief Scientific Officer
Walid Abi-Saab Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
GALAPAGOS NV-28.43%4 557
MODERNA, INC.102.97%85 140
LONZA GROUP AG13.57%52 316
IQVIA HOLDINGS INC.35.24%46 441
CELLTRION, INC.-22.42%33 893
SEAGEN INC.-10.43%28 470